Temporary Wall Systems celebrates new location in the Puget Sound region of Washington State
Local owners Brendan and Courtney Mahoney want to provide local jobs with a company that also offers eco-friendly construction containment…
Vivet Therapeutics Presents Interim Data from its Phase 1/2 GATEWAY Trial for the Treatment of Wilson Disease at EASL Congress 2024
VTX-801 increased ceruloplasmin ferroxidase activity and improved liver histology Encouraging safety and tolerability with no serious adverse events reported PARIS,…
High-Speed Data Converter Market Poised to Reach $4.2 Billion by 2029: Growing Demand Driven by 5G Infrastructure and IoT Adoption
The high-speed data converter market is booming with the demand for faster data processing across industries. Advanced solutions are crucial…
Venerable Yin Shun Attends the Cremation Ceremony for Samdech Preah Agga Maha Sangharajadhipati Tep Vong
PHNOM PENH, Cambodia, June 5, 2024 /PRNewswire/ -- On June 3, 2024, one hundred days after the passing of Samdech Preah…
Global Times: Digitization brings ancient treasures alive as China celebrates Cultural and Natural Heritage Day
BEIJING, June 5, 2024 /PRNewswire/ -- When the metaverse meets museums, visitors are able to travel to the past to build…
Samsung reportedly achieves technical breakthrough, stacking 3D DRAM to 16 layers
TAIPEI, June 5, 2024 /PRNewswire/ -- According to the news report from the technology-focused media DIGITIMES Asia, Samsung Electronics has successfully…
Testsigma raises $8.2M led by MassMutual Ventures
Unveils new GenAI capabilities and launches new product designed for Salesforce ecosystem BENGALURU, India, June 5, 2024 /PRNewswire/ -- AI-powered,…
Resolution Therapeutics Announces New Breakthrough Clinical Data for Macrophage Cell Therapy in End Stage Liver Disease at EASL 2024
MATCH Phase 2 data underscores significant potential of macrophage cell therapy treatment for advanced liver cirrhosis Resolution Therapeutics presents novel…
Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations
CASTRES, France, June 5, 2024 /PRNewswire/ -- Pierre Fabre Laboratories today announced the filing of an investigational new drug ("IND") application…
Smartphone Photo Printers Market to Reach $37.0 Billion Globally by 2032 at 7.1% CAGR: Allied Market Research
The increasing consumer demand for on-the-go, tangible photo printing solutions and the emergence of cost-effective & efficient printing technologies are…
For Germany’s He Chen, capital is an amazing place
BEIJING, June 5, 2024 /PRNewswire/ -- A news report from China Daily: "Hello everyone! This is Adrian from Germany!" At…
Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress
Highlights from the Data Presentation Initial immunogenicity (n=9) and ongoing safety data (n=13) presented in chronically HBV-infected patients following a…
↑